255 related articles for article (PubMed ID: 11145253)
1. Immunohistochemical study of microphthalmia transcription factor and tyrosinase in angiomyolipoma of the kidney, renal cell carcinoma, and renal and retroperitoneal sarcomas: comparative evaluation with traditional diagnostic markers.
Zavala-Pompa A; Folpe AL; Jimenez RE; Lim SD; Cohen C; Eble JN; Amin MB
Am J Surg Pathol; 2001 Jan; 25(1):65-70. PubMed ID: 11145253
[TBL] [Abstract][Full Text] [Related]
2. Melanoma markers in angiomyolipoma of the liver and kidney: a comparative study.
Makhlouf HR; Ishak KG; Shekar R; Sesterhenn IA; Young DY; Fanburg-Smith JC
Arch Pathol Lab Med; 2002 Jan; 126(1):49-55. PubMed ID: 11800647
[TBL] [Abstract][Full Text] [Related]
3. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.
Miettinen M; Fernandez M; Franssila K; Gatalica Z; Lasota J; Sarlomo-Rikala M
Am J Surg Pathol; 2001 Feb; 25(2):205-11. PubMed ID: 11176069
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of melanocytic markers in myoid, lipomatous, and vascular components of renal angiomyolipomas.
Roma AA; Magi-Galluzzi C; Zhou M
Arch Pathol Lab Med; 2007 Jan; 131(1):122-5. PubMed ID: 17227112
[TBL] [Abstract][Full Text] [Related]
5. Expression of KIT (CD117) in angiomyolipoma.
Makhlouf HR; Remotti HE; Ishak KG
Am J Surg Pathol; 2002 Apr; 26(4):493-7. PubMed ID: 11914628
[TBL] [Abstract][Full Text] [Related]
6. Renal angiomyolipoma: further immunophenotypic characterization of an expanding morphologic spectrum.
Stone CH; Lee MW; Amin MB; Yaziji H; Gown AM; Ro JY; Têtu B; Paraf F; Zarbo RJ
Arch Pathol Lab Med; 2001 Jun; 125(6):751-8. PubMed ID: 11371226
[TBL] [Abstract][Full Text] [Related]
7. Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparations.
Sheffield MV; Yee H; Dorvault CC; Weilbaecher KN; Eltoum IA; Siegal GP; Fisher DE; Chhieng DC
Am J Clin Pathol; 2002 Dec; 118(6):930-6. PubMed ID: 12472287
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical and reverse transcription-polymerase chain reaction expression analysis of tyrosinase and microphthalmia-associated transcription factor in angiomyolipomas.
Jungbluth AA; King R; Fisher DE; Iversen K; Coplan K; Kolb D; Williamson B; Chen YT; Stockert E; Old LJ; Busam KJ
Appl Immunohistochem Mol Morphol; 2001 Mar; 9(1):29-34. PubMed ID: 11277411
[TBL] [Abstract][Full Text] [Related]
9. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics.
Koch MB; Shih IM; Weiss SW; Folpe AL
Am J Surg Pathol; 2001 Jan; 25(1):58-64. PubMed ID: 11145252
[TBL] [Abstract][Full Text] [Related]
10. Immunoprofile of MITF, tyrosinase, melan-A, and MAGE-1 in HMB45-negative melanomas.
Xu X; Chu AY; Pasha TL; Elder DE; Zhang PJ
Am J Surg Pathol; 2002 Jan; 26(1):82-7. PubMed ID: 11756773
[TBL] [Abstract][Full Text] [Related]
11. Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.
Granter SR; Weilbaecher KN; Quigley C; Fletcher CD; Fisher DE
Am J Dermatopathol; 2001 Jun; 23(3):185-9. PubMed ID: 11391097
[TBL] [Abstract][Full Text] [Related]
12. PNL2: an adjunctive biomarker for renal angiomyolipomas and perivascular epithelioid cell tumours.
Gulavita P; Fletcher CDM; Hirsch MS
Histopathology; 2018 Feb; 72(3):441-448. PubMed ID: 28837273
[TBL] [Abstract][Full Text] [Related]
13. HMB45 and melan-A expression in renal angiomyolipoma and their significance for the diagnosis.
Tuna EB; Lebe B; Yörükoğlu K
Tumori; 2003; 89(1):46-8. PubMed ID: 12729361
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotypic differences between uveal and cutaneous melanomas.
Iwamoto S; Burrows RC; Kalina RE; George D; Boehm M; Bothwell MA; Schmidt R
Arch Ophthalmol; 2002 Apr; 120(4):466-70. PubMed ID: 11934320
[TBL] [Abstract][Full Text] [Related]
15. Microphthalmia transcription factor: a sensitive and specific marker for malignant melanoma in cytologic specimens.
Dorvault CC; Weilbaecher KN; Yee H; Fisher DE; Chiriboga LA; Xu Y; Chhieng DC
Cancer; 2001 Oct; 93(5):337-43. PubMed ID: 11668469
[TBL] [Abstract][Full Text] [Related]
16. Expression of melanocyte-associated markers gp-100 and Melan-A/MART-1 in angiomyolipomas. An immunohistochemical and rt-PCR analysis.
Jungbluth AA; Iversen K; Coplan K; Williamson B; Chen YT; Stockert E; Old LJ; Busam KJ
Virchows Arch; 1999 May; 434(5):429-35. PubMed ID: 10389626
[TBL] [Abstract][Full Text] [Related]
17. Renal epithelioid angiomyolipoma--a close mimic of renal cell carcinoma. Report of a case and review of the literature.
Svec A; Velenská Z
Pathol Res Pract; 2005; 200(11-12):851-6. PubMed ID: 15792132
[TBL] [Abstract][Full Text] [Related]
18. Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa.
Prasad ML; Jungbluth AA; Iversen K; Huvos AG; Busam KJ
Am J Surg Pathol; 2001 Jun; 25(6):782-7. PubMed ID: 11395556
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical evaluation of necrotic malignant melanomas.
Nonaka D; Laser J; Tucker R; Melamed J
Am J Clin Pathol; 2007 May; 127(5):787-91. PubMed ID: 17439838
[TBL] [Abstract][Full Text] [Related]
20. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis.
El Shabrawi-Caelen L; Kerl H; Cerroni L
Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]